Where do you find a clear signal in a world of static?

In a time of rapid change cut through the noise,

the economist goes beyond the headlines to decode the forces shaping today and defining tomorrow.

Get the full story.

It's more than news.

It's a trusted global perspective.

The economist know which way is up.

The views expressed on this podcast are those of the participants, not of Roiders' news.

Welcome to the Views Room, a weekly podcast brought to you by Reuters. I'm Rob Cox, the editor

of breaking views coming to you from Zurich,

Switzerland. For this week's edition, I spoke to my colleagues Amy Donnellin in Ireland and

Neil Unmac in London about the halting efforts to deliver COVID-19 vaccinations in Europe.

Having just gotten back from the U.S., where just about everyone I saw was either jabbed already

or had their first shot scheduled,

I wanted to understand better why things are so far behind the U.S. and the U.K.

on the European continent, including here in Switzerland.

As you'll hear, it's a combination of factors, starting with the limited supply of vaccines.

But there also appears to be something deeper, a kind of mistrust in general of vaccinations

in parts of Europe. And there is what looks like a sort of general risk aversion, which may explain

the panic in recent days of her side effects stemming from the AstraZeneca Oxford vaccine.

To be honest, I think there's something else at work. It may come down to the differing appetites for managing risk among developed societies.

That determines their willingness or lack thereof to embrace innovation, put their faith

...